Immune profile analysis of peripheral blood and tumors of lung cancer patients treated with immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibitors (ICIs) have become central to lung cancer drug therapy, and establishing biomarkers that can predict effects and adverse events (AEs) is awaited. We prospectively analyzed the association between the immune-related molecular expression in peripheral blood mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichiki, Yoshinobu, Fukuyama, Takashi, Ueno, Mari, Kanasaki, Yoshiro, Goto, Hidenori, Takahashi, Mai, Mikami, Shuji, Kobayashi, Noritada, Nakanishi, Kozo, Hayashi, Shinichi, Ishida, Tsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742629/
https://www.ncbi.nlm.nih.gov/pubmed/36519023
http://dx.doi.org/10.21037/tlcr-22-421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742629/
https://www.ncbi.nlm.nih.gov/pubmed/36519023
http://dx.doi.org/10.21037/tlcr-22-421

Ejemplares similares